|
W. L. GORE & ASSOCIATES, INC. GORE® CARDIOFORM ASD OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER
|
Back to Search Results |
|
| Catalog Number |
ASD32A |
| Medical Device Problem Code |
Patient-Device Incompatibility (2682)
|
| Health Effect - Clinical Code |
Arrhythmia (1721)
|
| Date of Event |
09/08/2025
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
The gore® cardioform septal occluder instructions for use list arrhythmia, such as atrial fibrillation or flutter, requiring treatment as a potential device or procedure related adverse event.W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|
| |
|
Event or Problem Description
|
|
It was reported that an 11-year-old female underwent atrial septal defect closure on (b)(6), 2025, using a 32 mm gore® cardioform asd occluder.Postoperatively, the patient began experiencing dizziness and near-syncope, which have progressively increased in frequency.A first-degree atrioventricular (av) block was noted post-procedure but has since resolved.The patient was subsequently hospitalized and evaluated for mri without contrast.Concerns regarding mri safety, including potential device movement and/or heating, were raised by the patient¿s guardians.As a result, a decision was made to forego mri evaluation on (b)(6), 2026.The first-degree av block was treated with a short course of steroids.
|
| |
|
Search Alerts/Recalls
|
|
|